Merck 2010 Annual Report Download - page 187

In accordance with the provisions of the Articles of Association, E. Merck KG has a 70.274% interest
in the profit/loss of Merck KGaA while Merck KGaA has an interest of 29.726% in the profit/loss of
E. Merck KG. Merck KGaA’s profit from ordinary activities adjusted for trade income tax and extraor-
dinary result, on which the appropriation of its profit is based, amounts to EUR 617.4 million (2009:
EUR 310.1 million). Merck KGaA transferred EUR 433.9 million of its profit to E. Merck KG (2009:
EUR 217.9 million). The profit/loss of E. Merck KG, on which the appropriation of profit/loss is based,
amounts to EUR 12.3 million (2009: EUR 1.9 million). Consequently, this results in a profit transfer
to Merck KGaA of EUR 3.7 million (2009: EUR 0.6 million).
Moreover, in 2010 EUR 43.0 million (2009: EUR 26.8 million) was transferred by Merck & Cie to
E. Merck KG.
For 2009, a dividend of EUR 1.00 per share was distributed. The dividend proposal for fiscal 2010
will be EUR 1.25 per share, corresponding to a total dividend payment of EUR 80.8 million to
shareholders.
The following table shows the development of transactions taken cumulatively and directly to the
equity of shareholders of the parent company:
EUR million
Available-for-
sale current and
non-current
financial assets
Derivative
financial
instruments
Exchange dif-
ferences on
translating
foreign
operations Total
    
Gains/losses recognized immediately
in equity 33.8 –16.6 –15.5 1.7
Changes in scope of consolidation/Others – – – –
    
    
Gains/losses recognized immediately
in equity –21.8 –108.6 834.6 704.2
Changes in scope of consolidation/Others –0.1 – 0.1 –
     
The increase in the currency translation difference results mainly from the decline in the value of
the euro versus the Swiss franc and the U.S. dollar.

The classification of asset and income figures as well as of other key figures by business sector or
by region in accordance with IFRS 8 is presented in “Segment Reporting”. The segments presented
correspond to the internal organizational and reporting structure of the Merck Group. Within the
Merck Serono division, we focus on specialist therapeutic areas and market innovative prescrip-
tion drugs of chemical and biotechnological origin. The Consumer Health Care division comprises
Merck’s business with high-quality over-the-counter products for preventive health care and
self-treatment of minor ailments. These two divisions form the Pharmaceuticals business sector.
Company 183Management Report Corporate governance Consolidated Financial Statements
Notes
More information